Document is current
Any future updates will be listed below
-
Authors
Gómez-Ambrosi, Javier https://orcid.org/0000-0001-5601-1604
González-Alva, Manuel U.
Silva, Camilo https://orcid.org/0000-0002-3466-1291
Salvador, Javier https://orcid.org/0000-0002-3393-8156
Frühbeck, Gema https://orcid.org/0000-0002-8305-7154
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI22/00745)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CIBEROBN)
- License Information
-
More Information
Article History
Received: 6 October 2025
Accepted: 9 March 2026
First Online: 26 March 2026
Competing interests
: G.F. declares payment of honoraria for lectures from Novo Nordisk as Member of the OPEN Spain Initiative as well as payment of honoraria for attendance to Advisory Boards from Lilly, Novo Nordisk, Regeneron and AstraZeneca. The other authors declared no conflict of interest.
